NCT00206635 - Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis | Biotech Hunter

Enrollment

432

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

December 31, 2005

Conditions

Multiple Sclerosis

Interventions

DRUG

Interferon beta-1b (Betaseron, BAY86-5046)

Betaseron was not administered as part of this study, only the treatment and disease status was assessed. As part of the MRI analysis Gadolinium was administered in patients who underwent this procedure

Trial Locations (9)

Unknown

Many Locations